Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chubb
Queensland Health
Express Scripts
Merck
Julphar
Mallinckrodt
Covington
Harvard Business School

Generated: November 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018553

« Back to Dashboard

NDA 018553 describes INDERAL LA, which is a drug marketed by Ani Pharms Inc and is included in one NDA. It is available from six suppliers. Additional details are available on the INDERAL LA profile page.

The generic ingredient in INDERAL LA is propranolol hydrochloride. There are twenty-one drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the propranolol hydrochloride profile page.
Summary for 018553
Tradename:INDERAL LA
Applicant:Ani Pharms Inc
Ingredient:propranolol hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018553
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 018553
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INDERAL LA propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018553 NDA AUTHORIZED GENERIC Blenheim Pharmacal, Inc. 10544-286 10544-286-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10544-286-30)
INDERAL LA propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018553 NDA AUTHORIZED GENERIC Rouses Point Pharm 43478-900 43478-900-88 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43478-900-88)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength160MG
Approval Date:Apr 19, 1983TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength80MG
Approval Date:Apr 19, 1983TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength120MG
Approval Date:Apr 19, 1983TE:ABRLD:Yes

Expired US Patents for NDA 018553

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ani Pharms Inc INDERAL LA propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018553-004 Mar 18, 1987 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc INDERAL LA propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018553-001 Apr 19, 1983 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc INDERAL LA propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018553-003 Apr 19, 1983 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc INDERAL LA propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018553-002 Apr 19, 1983 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Julphar
AstraZeneca
Covington
Harvard Business School
McKinsey
Cipla
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.